Cyfra 21-1 – Tumor Marker Analysis
550,00 د.إThe Cyfra 21-1 test is a specialized tumor marker analysis. It measures the levels of Cytokeratin 19 fragments in your blood serum.
Sample Type : Serum
Methodology : TBA
TAT : 10 Days
Showing all 4 results
-
-
Male Cancer Marker Panel – Early Blood Test for Prostate, Liver & Pancreatic Cancer
650,00 د.إIncludes the following parameters:
- Alpha-Fetoprotein (AFP)
- CA 19.9, Serum (Pancreatic Cancer Marker)
- Carcinoembryonic Antigen (CEA), Serum
- Prostate-Specific Antigen (PSA), Total Serum
- Prostate-Specific Antigen (PSA), Free Serum
- Human Chorionic Gonadotropin (HCG)
-
Tumor Markers Screen (Female)–(CEA, CA 15.3, CA 19.9, CA 125, AFP)
900,00 د.إTumor Markers Screen (Female) is a powerful, non-invasive blood test that measures five critical tumor markers: CEA, CA 15.3, CA 19.9, CA 125, and AFP.
Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day -
Tumor Markers Screen (Male)
850,00 د.إTumor Markers Screen (Male) is a comprehensive 6-parameter surveillance system. By analyzing specific biomarkers in your blood, CA 19.9, CEA, PSA-Total, PSA-Free, AFP, and BhCG, this panel offers a panoramic view of your cancer risk.
Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day
